Astera Labs (NASDAQ:ALAB) Updates Q4 2025 Earnings Guidance

Astera Labs (NASDAQ:ALAB) issued an update on its fourth quarter 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.50-0.510 for the period, compared to the consensus earnings per share estimate of 0.340. The company issued revenue guidance of -, compared to the consensus revenue estimate of $216.8 million.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB traded down $12.25 during midday trading on Tuesday, hitting $179.31. 8,777,411 shares of the stock were exchanged, compared to its average volume of 5,234,111. The company has a market capitalization of $29.80 billion, a PE ratio of 320.20, a P/E/G ratio of 4.66 and a beta of 1.38. Astera Labs has a 52-week low of $47.13 and a 52-week high of $262.90. The business’s fifty day simple moving average is $196.78 and its two-hundred day simple moving average is $137.86.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.26 earnings per share for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.13). Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, equities analysts anticipate that Astera Labs will post 0.34 EPS for the current year.

Analysts Set New Price Targets

A number of research firms recently commented on ALAB. Morgan Stanley increased their price objective on shares of Astera Labs from $155.00 to $200.00 and gave the stock an “overweight” rating in a report on Friday, August 29th. Stifel Nicolaus upped their target price on shares of Astera Labs from $174.00 to $185.00 and gave the stock a “buy” rating in a research report on Friday, October 17th. Jefferies Financial Group raised their price target on shares of Astera Labs from $95.00 to $130.00 and gave the company a “buy” rating in a report on Tuesday, July 22nd. Cowen assumed coverage on shares of Astera Labs in a research report on Tuesday, September 30th. They issued a “hold” rating for the company. Finally, Needham & Company LLC increased their price objective on Astera Labs from $100.00 to $170.00 and gave the company a “buy” rating in a research report on Wednesday, August 6th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $162.06.

Insider Transactions at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 25,000 shares of the firm’s stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $173.42, for a total value of $4,335,500.00. Following the completion of the transaction, the director owned 99,154 shares in the company, valued at $17,195,286.68. This trade represents a 20.14% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the transaction, the director directly owned 385,863 shares of the company’s stock, valued at $66,858,482.01. This trade represents a 32.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 1,092,997 shares of company stock worth $192,231,120. Company insiders own 12.50% of the company’s stock.

Institutional Trading of Astera Labs

Hedge funds and other institutional investors have recently modified their holdings of the stock. Diversify Wealth Management LLC bought a new position in Astera Labs in the second quarter valued at approximately $106,000. Visionary Wealth Advisors acquired a new stake in shares of Astera Labs in the 2nd quarter valued at $205,000. Tower Research Capital LLC TRC boosted its holdings in shares of Astera Labs by 506.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 2,486 shares of the company’s stock valued at $225,000 after purchasing an additional 2,076 shares in the last quarter. Ausdal Financial Partners Inc. bought a new position in shares of Astera Labs in the 2nd quarter valued at $257,000. Finally, Empowered Funds LLC lifted its position in shares of Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after buying an additional 4,183 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.